BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2002
View Archived Issues
Gruenenthal patents novel opioid analgesics
Read More
Novel factor Xa inhibitors claimed by Merck KGaA
Read More
BMS presents new polycyclic DNA topoisomerase I inhibitors
Read More
Sankyo describes Th1-selective immunosuppressants
Read More
PPARgamma ligands for use in obesity, bone diseases, lipoprotein disorders, etc.
Read More
GSK claims Lp-PLA2 inhibitors for use in atherosclerosis
Read More
The NMDA receptor antagonist LY-235959 attenuates cocaine conditioning in rats
Read More
Dopamine uptake inhibitors and the attenuation of cocaine selfadministration
Read More
Selegiline enhances smoking cessation rates among nicotine-dependent smokers
Read More
Barr completes acquisition of Enhance assets
Read More
Roche and Genmab expand antibody collaboration
Read More
Pfizer returns pagoclone rights to Indevus
Read More
Dusa to reacquire rights to Levulan PDT from Schering AG
Read More
Pharmos receives grant to fund development of dexanabinol for traumatic brain injury
Read More
Hemosol revises timetable for Hemolink
Read More
NIDA and Britannia stop phase III trials of first nonopiate detoxification agent
Read More
Minocycline effective in an experimental model of amyotrophic lateral sclerosis (ALS)
Read More
Oral streptogramin shows promise for community-acquired infections
Read More
NU:UB-73 exerts antitumor activity via an unidentified metabolite
Read More
Antitumor activity of J-103 involves Fas/FasL system
Read More
Successful in vivo gene therapy of Gaucher's disease discussed at ASGT meeting
Read More
Merck & Co. revises Zocor prescribing information
Read More
AstraZeneca and Pierre Fabre team up to evaluate Iressa in combination with vinorelbine in NSCLC
Read More
Preliminary data for Angiozyme in combination with chemotherapy in metastatic colorectal cancer
Read More
Shire files for approval of Fosrenol in Canada
Read More
Fujisawa to market Zindaclin in continental Europe
Read More
CX-516 shows promising results in Alzheimer's disease
Read More
Anadys and Gilead collaborate on novel antiviral compound discovery
Read More
